Bio-Techne Corp. (TECH)
72.34
-0.05
(-0.07%)
USD |
NASDAQ |
Aug 25, 12:17
Bio-Techne Enterprise Value : 11.35B for Aug. 24, 2026
Enterprise Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Enterprise Value Data
| Date | Value |
|---|---|
| August 24, 2026 | 11.35B |
| August 21, 2026 | 11.34B |
| August 20, 2026 | 11.34B |
| August 19, 2026 | 11.37B |
| August 18, 2026 | 11.33B |
| August 17, 2026 | 11.35B |
| August 14, 2026 | 11.36B |
| August 13, 2026 | 11.32B |
| August 12, 2026 | 11.33B |
| August 11, 2026 | 11.32B |
| August 10, 2026 | 11.31B |
| August 07, 2026 | 11.34B |
| August 06, 2026 | 11.28B |
| August 05, 2026 | 11.29B |
| August 04, 2026 | 11.31B |
| August 03, 2026 | 11.32B |
| July 31, 2026 | 11.31B |
| July 30, 2026 | 11.30B |
| July 29, 2026 | 11.30B |
| July 28, 2026 | 11.30B |
| July 27, 2026 | 11.23B |
| July 24, 2026 | 11.23B |
| July 23, 2026 | 11.26B |
| July 22, 2026 | 11.26B |
| July 21, 2026 | 11.24B |
| Date | Value |
|---|---|
| July 20, 2026 | 11.24B |
| July 17, 2026 | 11.31B |
| July 16, 2026 | 11.26B |
| July 15, 2026 | 11.21B |
| July 14, 2026 | 11.17B |
| July 13, 2026 | 11.19B |
| July 10, 2026 | 11.18B |
| July 09, 2026 | 11.16B |
| July 08, 2026 | 11.13B |
| July 07, 2026 | 11.08B |
| July 06, 2026 | 11.12B |
| July 02, 2026 | 11.11B |
| July 01, 2026 | 11.14B |
| June 30, 2026 | 11.08B |
| June 29, 2026 | 11.18B |
| June 26, 2026 | 11.19B |
| June 25, 2026 | 11.15B |
| June 24, 2026 | 9.295B |
| June 23, 2026 | 8.886B |
| June 22, 2026 | 8.784B |
| June 18, 2026 | 9.149B |
| June 17, 2026 | 8.689B |
| June 16, 2026 | 8.850B |
| June 15, 2026 | 8.872B |
| June 12, 2026 | 8.532B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Danaher Corp. | 174.72B |
| Agilent Technologies, Inc. | 44.85B |
| Thermo Fisher Scientific, Inc. | 271.08B |
| Waters Corp. | 45.26B |
| Bruker Corp. | 10.34B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | 54.62M |
| Revenue (Quarterly) | 321.19M |
| Total Expenses (Quarterly) | 266.57M |
| EPS Diluted (Quarterly) | 0.3479 |
| Gross Profit Margin (Quarterly) | 65.82% |
| Profit Margin (Quarterly) | 17.01% |
| Earnings Yield | 1.60% |
| Operating Earnings Yield | 2.36% |
| Normalized Earnings Yield | 1.700 |